What is the Org number of Apim Therapeutics AS?

Apim Therapeutics AS is registered with Brønnøysundsregistrene under Org 894298952.

What is the revenue of Apim Therapeutics AS?

Apim Therapeutics AS reported revenue of 65,0k kr in 2024.

Apim Therapeutics AS employs 2 people as of the latest annual report.

Konstantinos Alevizopoulos is the CEO of Apim Therapeutics AS, in role since 2010.

Erlend Petter Skagseth chairs the board of Apim Therapeutics AS, in role since 2023.

Apim Therapeutics AS's registered address is Yrjars Gate 29, 7130 Brekstad.

ASActive

Org 894298952Yrjars Gate 29, 7130 BrekstadWholesale of pharmaceutical and medical goods· NACE 4646Est. 2009 · 16 years old2 employees

Actively employed in the business

Name	Role	Member since
Current (1)
KA Konstantinos Alevizopoulos Chief Executive Officer	Chief Executive Officer	2010

Former (2)


BG Birgitte Gangmark Villmo Observer	Observer	2019 – 2021
EW Erik Wold Observer	Observer	2023 – 2023

Non-executive oversight

Name	Role	Member since
Current (7)
MO Marit Otterlei Board of Directors	Board of Directors	2023
BG Birgitte Gangmark Villmo Board of Directors	Board of Directors	2023
MW Martin Welschof Board of Directors	Board of Directors	2023
EP Erlend Petter Skagseth Chairman	Chairman	2023
FA Farzad Abdi-Dezfuli Board of Directors	Board of Directors	2023
JA Jørgen Andre Nilsen Board of Directors	Board of Directors	2023
GB Gökhan Batur Board of Directors	Board of Directors	2023

Former (1)


SK Stener Kvinnsland Board of Directors	Board of Directors	2023 – 2024

As of last annual report

Shareholder	Type	Ownership	Votes	Since
Sarsia Seed As	Company	21.41%	21.41%	2025
Investinor Direkte As	Company	15%	15%	2025
Trond Mohn Forskningsstiftelse	Company	13.27%	13.27%	2025
Stiftelsen Universitetsforskning Bergen	Company	6.47%	6.47%	2025
Harmonium Invest As	Company	3.53%	3.53%	2025
Torsen Tankers & Towers As	Company	3.11%	3.11%	2025
Birk Venture As	Company	2.45%	2.45%	2025
Oskar Investment As	Company	2.25%	2.25%	2025
Altitude Explorer As	Company	2.02%	2.02%	2025
Hmh Invest As	Company	1.81%	1.81%	2025
Skips As Tudor	Company	1.81%	1.81%	2025
Hering As	Company	1.8%	1.8%	2025
Krakr As	Company	1.61%	1.61%	2025
Marit Otterlei	Individual	1.54%	1.54%	2025
Turtle Invest As	Company	1.47%	1.47%	2025
Ro Invest As	Company	1.45%	1.45%	2025
Norda Asa	Company	1.13%	1.13%	2025
Jens Petter Rønning	Individual	1.1%	1.1%	2025
Avanto Opportunities V As	Company	1.05%	1.05%	2025

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.